UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging

Background Osteoporosis has gradually become a public health problem in the world. However, the exact molecular mechanism of osteoporosis still remains unclear. Senescence and osteogenic differentiation inhibition of bone marrow mesenchymal stem cells (BMSCs ) are supposed to play an important part...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yalin Liu, Guangping Cai, Peng Chen, Tiejian Jiang, Zhuying Xia
Formato: article
Lenguaje:EN
Publicado: PeerJ Inc. 2021
Materias:
R
Acceso en línea:https://doaj.org/article/8005adf9ae834890bb5a191d5798d839
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8005adf9ae834890bb5a191d5798d839
record_format dspace
spelling oai:doaj.org-article:8005adf9ae834890bb5a191d5798d8392021-11-20T15:05:05ZUBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging10.7717/peerj.122532167-8359https://doaj.org/article/8005adf9ae834890bb5a191d5798d8392021-11-01T00:00:00Zhttps://peerj.com/articles/12253.pdfhttps://peerj.com/articles/12253/https://doaj.org/toc/2167-8359Background Osteoporosis has gradually become a public health problem in the world. However, the exact molecular mechanism of osteoporosis still remains unclear. Senescence and osteogenic differentiation inhibition of bone marrow mesenchymal stem cells (BMSCs ) are supposed to play an important part in osteoporosis. Methods We used two gene expression profiles (GSE35956 and GSE35958) associated with osteoporosis and selected the promising gene Ubiquitin-conjugating enzyme E2 E3 (UBE2E3). We then verified its function and mechanism by in vitro experiments. Results UBE2E3 was highly expressed in the bone marrow and positively associated with osteogenesis related genes. Besides, UBE2E3 expression reduced in old BMSCs compared with that in young BMSCs. In in vitro experiments, knockdown of UBE2E3 accelerated cellular senescence and inhibited osteogenic differentiation of young BMSCs. On the other hand, overexpression of UBE2E3 attenuated cellular senescence as well as enhanced osteogenic differentiation of old BMSCs. Mechanistically, UBE2E3 might regulate the nuclear factor erythroid 2-related factor (Nrf2) and control its function, thus affecting the senescence and osteogenic differentiation of BMSCs. Conclusion UBE2E3 may be potentially involved in the pathogenesis of osteoporosis by regulating cellular senescence and osteogenic differentiation of BMSCs.Yalin LiuGuangping CaiPeng ChenTiejian JiangZhuying XiaPeerJ Inc.articleUBE2E3OsteoporosisOsteogenic differentiationSenescenceNrf2MedicineRENPeerJ, Vol 9, p e12253 (2021)
institution DOAJ
collection DOAJ
language EN
topic UBE2E3
Osteoporosis
Osteogenic differentiation
Senescence
Nrf2
Medicine
R
spellingShingle UBE2E3
Osteoporosis
Osteogenic differentiation
Senescence
Nrf2
Medicine
R
Yalin Liu
Guangping Cai
Peng Chen
Tiejian Jiang
Zhuying Xia
UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging
description Background Osteoporosis has gradually become a public health problem in the world. However, the exact molecular mechanism of osteoporosis still remains unclear. Senescence and osteogenic differentiation inhibition of bone marrow mesenchymal stem cells (BMSCs ) are supposed to play an important part in osteoporosis. Methods We used two gene expression profiles (GSE35956 and GSE35958) associated with osteoporosis and selected the promising gene Ubiquitin-conjugating enzyme E2 E3 (UBE2E3). We then verified its function and mechanism by in vitro experiments. Results UBE2E3 was highly expressed in the bone marrow and positively associated with osteogenesis related genes. Besides, UBE2E3 expression reduced in old BMSCs compared with that in young BMSCs. In in vitro experiments, knockdown of UBE2E3 accelerated cellular senescence and inhibited osteogenic differentiation of young BMSCs. On the other hand, overexpression of UBE2E3 attenuated cellular senescence as well as enhanced osteogenic differentiation of old BMSCs. Mechanistically, UBE2E3 might regulate the nuclear factor erythroid 2-related factor (Nrf2) and control its function, thus affecting the senescence and osteogenic differentiation of BMSCs. Conclusion UBE2E3 may be potentially involved in the pathogenesis of osteoporosis by regulating cellular senescence and osteogenic differentiation of BMSCs.
format article
author Yalin Liu
Guangping Cai
Peng Chen
Tiejian Jiang
Zhuying Xia
author_facet Yalin Liu
Guangping Cai
Peng Chen
Tiejian Jiang
Zhuying Xia
author_sort Yalin Liu
title UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging
title_short UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging
title_full UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging
title_fullStr UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging
title_full_unstemmed UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging
title_sort ube2e3 regulates cellular senescence and osteogenic differentiation of bmscs during aging
publisher PeerJ Inc.
publishDate 2021
url https://doaj.org/article/8005adf9ae834890bb5a191d5798d839
work_keys_str_mv AT yalinliu ube2e3regulatescellularsenescenceandosteogenicdifferentiationofbmscsduringaging
AT guangpingcai ube2e3regulatescellularsenescenceandosteogenicdifferentiationofbmscsduringaging
AT pengchen ube2e3regulatescellularsenescenceandosteogenicdifferentiationofbmscsduringaging
AT tiejianjiang ube2e3regulatescellularsenescenceandosteogenicdifferentiationofbmscsduringaging
AT zhuyingxia ube2e3regulatescellularsenescenceandosteogenicdifferentiationofbmscsduringaging
_version_ 1718419433795354624